Kodiak Sciences (KOD) Stock Price, Quote, News & History | Benzinga

Kodiak Sciences Inc (KOD) Stock Price, Quote, News & History

KODNASDAQ

Trade with Public

Trade with Public

$39.84

At close: Aug 21, 5:00 PM EST

$39.84

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 699.82K

Day Range

- - -

52 Wk Range

8.29 - 47.84

Market Cap

$2.50B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

25.76%

Days to Cover

20.61

Recent Kodiak Sciences Inc. News

Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Other big gainers in today's session include FuelCell Energy Inc (NASDAQ: FCEL) up 17.6%, BitVentures Limited (NASDAQ: BVC) up 14.1%, and ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) up 10.3% after receiving a positive recommendation for a market authorization in Europe.

Avi Kapoor

This Pitney Bowes Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

Top analysts upgraded Starz Entertainment, Primoris Services, Pitney Bowes, Kodiak Sciences, and StandardAero. See what they think of PBI stock.

Avi Kapoor

Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers

The small-cap Russell 2000 punched through to an intraday record high on Friday, capping a furious 13-day rally.

Erica Kollmann

PVH, Micron, Intel And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rise, Dow Jones up 400+ points. PVH Corp beats expectations, shares jump 9.9%. Other big gainers include RGC, TH, PLAY, SHAZ, HTT, MFI, RZLV, FSLY, WDC, KOD, LITE, SanDisk.

Avi Kapoor

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

Kodiak Sciences Inc (NASDAQ: KOD) shares are trading higher Friday after positive Phase 3 GLOW2 results for Zenkuda in diabetic retinopathy.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-158.51M

Investing Cash Flow (TTM)

-1.40M

Financing Cash Flow (TTM)

181.64M

Free Cash Flow (TTM)

-159.90M

Capital Expenditure (TTM)

-1.40M

Net Change in Cash (TTM)

21.74M

Analyst Trends and Forecast

2

Mar

1

May

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.43B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

40.98

Earnings Yield % (TTM)

-10.52%

Earnings Yield % (FWD)

-9.41%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.97

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$125.90M

Debt to Equity

0.86

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 699.82K

Day Range

- - -

52 Wk Range

8.29 - 47.84

Market Cap

$2.50B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

25.76%

Days to Cover

20.61

About

Sector

Health Care

Industry

Biotechnology

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kodiak Sciences (KOD) stock?

A

You can purchase shares of Kodiak Sciences (NASDAQ:KOD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kodiak Sciences (KOD) competitors?

A

Other companies in Kodiak Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Kodiak Sciences (KOD) stock?

A

Kodiak Sciences has a consensus price target of $36.40.

Q

What is the current price for Kodiak Sciences (KOD)?

A

The stock price for Kodiak Sciences (NASDAQ: KOD) is $39.84 last updated August 20, 2026 at 4:00 PM EDT.

Q

Does Kodiak Sciences (KOD) pay a dividend?

A

There are no upcoming dividends for Kodiak Sciences.

Q

When is Kodiak Sciences (NASDAQ:KOD) reporting earnings?

A

Kodiak Sciences does not have any upcoming earnings scheduled.

Q

Is Kodiak Sciences (KOD) going to split?

A

There is no upcoming split for Kodiak Sciences.

Q

What sector and industry does Kodiak Sciences (KOD) operate in?

A

Kodiak Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.